26 May 2023
One Health AMR Partnership publishes draft Strategic Research Agenda
One Health Antimicrobial Resistance (OH AMR) is a co-funded European Partnership under the first Strategic Plan of Horizon Europe. It is expected to start in 2025. The first draft of the Strategic Research and Innovation Agenda (SRIA) which will guide the activities of the Partnership has now been published. The Partnership will coordinate and boost AMR research and innovation in an interdisciplinary One Health approach, contributing to advanced knowledge, innovative solutions and policy to reduce the burden of Antimicrobial Resistance.
The SRIA and the R&I objectives have been developed by the CSA DESIGN OH AMR together with the JPI AMR Scientific Advisory Board and other experts, through a series of consultations with Member States and stakeholders. The current SRIA should be considered as a preliminary draft and will be subjected to several consultations before it is adopted by the OH AMR partners by the start of the Partnership in 2025.